Ascrinvacumab (Anti-ACVRL1 / ALK-1)Ascrinvacumab (Anti-ACVRL1 / ALK-1)
Move your mouse over image or click to enlarge

Ascrinvacumab (Anti-ACVRL1 / ALK-1)

Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.
Cat# Size Price Qty Buy
A2594-1mg*25 1mg*25
£1,941.00
A2594-1mg*5 1mg*5
£647.00
A2594-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2594

Related Documents